The SEMALEAN study (2025): "Semaglutide treatment resulted in a 15% reduction in visceral fat," reports a meaningful reduction in visceral fat during therapy, which is important for reducing metabolic risk
The Commonality of Nausea with Semaglutide Nausea stands out as one of the most frequently reported side effects when starting GLP-1 medications like Semaglutide
These injections target and eliminate stubborn fat in specific body areas, resulting in a more sculpted and toned appearance
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3)
Lunch: Quinoa bowl with half a cup of cooked quinoa, four ounces of grilled chicken, black beans, corn, diced avocado, salsa, and lime juice